Inactive Instrument

Company IGEA Pharma N.V.

Equities

IGPH

NL0012768675

Medical Equipment, Supplies & Distribution

Business Summary

IGEA Pharma NV is a biopharmaceutical company based in the Netherlands. The Company focuses on research and development of biomedical solutions for the prevention of diabetes and Alzheimer's disease. Its offering portfolio includes medical testing devices and dietary supplements. The Company develops ALZ-1 Test, a blood test to measure and control level of free copper, also known as Free Copper II or Non-Ceruloplasmin Copper in the bloodstream, which is a major recognized modifiable risk factor for the Alzheimer's disease. The Company offers its services in the Netherlands.

Number of employees: 1

Managers

Managers TitleAgeSince
Chief Executive Officer - 23-04-23
Chief Operating Officer - -
Chief Tech/Sci/R&D Officer - -

Members of the board

Members of the board TitleAgeSince
Director/Board Member 64 18-12-13
Chairman - 23-04-23
Director/Board Member - 23-04-23
Chief Executive Officer - 23-04-23

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 337,030,142 222,024,074 ( 65.88 %) 0 65.88 %

Shareholders

NameEquities%Valuation
15,500,000 4.599 % 8 990 CHF

Company contact information

IGEA Pharma NV

Siriusdreef 17

2132 WT, Hoofddorp

+31 23 568 9494

http://www.4healthy.nl
address IGEA Pharma N.V.(IGPH)
  1. Stock Market
  2. Equities
  3. IGPH Stock
  4. Company IGEA Pharma N.V.